Zimmer Biomet Holdings Inc

ZBH: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
jn>LOCK|CnLOCK|<z&rb$dt

Zimmer Biomet Earnings: Steady Quarterly Results Keeps Firm on Track for 2025

Zimmer Biomet saw second-quarter revenue growth of 5% in constant currency and adjusted operating margin decline by 140 basis points, driven mainly by the acquisition of Paragon 28.

Sponsor Center